To intubate or not--that is the question: continuous positive airway pressure versus surfactant and extremely low birthweight infants.

Delivery and performance of surfactant replacement therapies to treat pulmonary disorders. Ther Deliv (2013) 0.78

Short- and intermediate-term outcomes of preterm infants receiving positive pressure ventilation in the delivery room. Crit Care Res Pract (2013) 0.78

Nasal CPAP in the delivery room for newborns with extremely low birth weight in a hospital in a developing country. Braz J Med Biol Res (2013) 0.75

Novel approaches to surfactant administration. Crit Care Res Pract (2012) 0.75

Respiratory system involvement in Costello syndrome. Am J Med Genet A (2016) 0.75

Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med (1971) 7.89

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics (2005) 4.49

Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics (2000) 4.49

Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics (1987) 4.10

Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics (2000) 3.48

Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA (2003) 2.70

Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics (2004) 2.41

The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed (2005) 2.32

Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr (2005) 2.25

Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics (2005) 2.09

Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2001) 2.04

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics (1999) 2.01

Is it safer to intubate premature infants in the delivery room? Pediatrics (2005) 1.81

Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2000) 1.79

Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev (2003) 1.75

Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev (2000) 1.52

Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project On Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics (2005) 1.43

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med (1994) 1.42

Short-term outcome after active perinatal management at 23-25 weeks of gestation. A study from two Swedish perinatal centres. Part 3: neonatal morbidity. Acta Paediatr (2004) 1.24

Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev (2001) 1.18

Survival and long-term neurodevelopmental outcome of extremely premature infants born at 23-26 weeks' gestational age at a tertiary center. Pediatrics (2004) 1.15

Sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery. Arch Dis Child Fetal Neonatal Ed (2006) 1.13

Positive end-expiratory pressure differentially alters pulmonary hemodynamics and oxygenation in ventilated, very premature lambs. J Appl Physiol (1985) (2005) 1.05

Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed (2004) 1.00

Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev (2002) 0.93

Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2000) 0.90

Impact of improved survival of very low-birth-weight infants on incidence and severity of bronchopulmonary dysplasia. Biol Neonate (2004) 0.88

Randomized controlled trial of very early continuous distending pressure in the management of preterm infants. Early Hum Dev (1987) 0.87

Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev (2005) 0.86

Developmental outcome of preterm infants after surfactant therapy: systematic review of randomized controlled trials. J Paediatr Child Health (2002) 0.86